pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol HMGCS1   
Synonyms HMGCS
Description 3-hydroxy-3-methylglutaryl-CoA synthase 1
Transcript NM_001098272   
Other Transcripts NM_002130   
Expression
Putative miRNA Targets on HMGCS1
3'UTR of HMGCS1
(miRNA target sites are highlighted)
>HMGCS1|NM_001098272|3'UTR
   1 GATACTCTGTGAGGTGCAAGACTTCAGGGTGGGGTGGGCATGGGGTGGGGGTATGGGAACAGTTGGAGGAATGGGATATC
  81 TGGGGATAATTTTAAAGGATTACATGTTATGTAAATTTTTATGTGACTGACATGGAGCCTGGATGACTATCGTGTACTTG
 161 GGAAAGTCTCTTTGCTCTATTTGCTGACATGCTTCCTGTTGTGGTCTGGCCAATGCCAAATGTACTCGAATGATGTTAAG
 241 GGCTCTGTAAAACTTCATACCTCTTTGGCCATTTGTATGCATGATGTTTGGTTTTTAAACATGGTATAATGAATTGTGTA
 321 CTTCTGTCAGAAGAAAGCAGAGGTACTAATCTCCAATTAAAAAATTTTTTAACATGTAAGAATTTTGTACTTTGAACAAC
 401 AAGATTACAGAAAGTACCTGTGGTTTTTGGAAAACATTTCTAGCTTGGGGAATGTGACAACATTCCCCAGTGTGGTAAAA
 481 TTGGGGTAAAATGTGGTAAAATGTGATACGCACAAACCCTTTGAAAATAGCAAAACAAACATGCCCTTTTTCTAAAATTG
 561 ATAAATCCTAAAGAGGAAGAAAAGAGCTGGGACAATAAAACACTGGCTCTGGAATCTGGAATGTTAAGTCCAGGCCAGCA
 641 GTGACAAAAGTTATTGTAATGACCTCTGAACAGAGAAACACTGCCATTGAAGAGGCTTCTGGTATAGAAAACATGGTACA
 721 TTCAGGAGCTGTGAATATAGCTCTAGGTGTGCTCCTGAATCAGTTCATGGTAGATTATGCTGAACAACAGTGAGATGTTA
 801 TTGGAGGTGTGGATGAGGGAGTTTGTTGTTGCAGTCCTTCTTTGCACCTTATTTTAAAGAATAAATGAAACATTTTTCTG
 881 GTTACTTTTTTAAAAATTTAAAATGGAAGGGAAGAATAGGGGCAGGGCATTATTAGGCTATTTCTGATGCTTCAGTGTTA
 961 TAAATTCAACATAGAGGCTGACAACCTAAATTCATGGTGTAACACAGCTCTTTTCCTTTTCCTTTTTTTTTTTTTTTTGG
1041 TATCTGTTCAATGAAAATAAGGTATGACCCAAGTTTTTACCTAGTCTGACTAGAAGTATTCCACTTCAAGGTCTGAAGTA
1121 GGACTTTTACCTTAAAAAACAACAACAAACAAAACTATCACACAGGATAGATAAGAAGATTGGTTAAACAGTTTTGTGTA
1201 GATCTTTTTGGTGCTGAACTATGACATGAGCCTTATAGATTGTAAAATAGGGATAGTTGGAACTAATGTACAGAACTAAA
1281 TTTTTTAAACTTTATTTGCTGTTAAATTCTGTGAAGTTTCAGTTATCTAAAATAAATATACACAAATATGAAATATAATG
1361 TTTCAGATTGCAAGGTAATATGTAATAGTAGTGTTTGTAAGATACTCTTGTCTAATATTAACTAGTAGTATTTTGATTTG
1441 TACAGTCATAATTTGTTAAAATGACTTCATTTAACATTCACTGATGTAGATTAATAATGTAAGTTCTGATTTAAAGAATG
1521 GTGGCAAAATGGTGCATGTAATACTTTTGCAAGTGTTGGGGAGATCGGTATGTTTTGAAAAGAGTAATTTAACTTTTGGG
1601 TGCCAGGAAATGGGTTTTCTCAAAGTCCATTGCCGGCAATGGGCAGGCCTGCAAATACTGGCACAGAGCATTAATCATAC
1681 ACCTTATTAACGGTGAGGTGAATAACTTTGAAATAAAGTTTTAGAGAAATGTTTCAGATACTTGAGTATTCTTTTTCACT
1761 CTTGAACTAACAACTTCGGCAAGAAATCAGCTAATATTCTATTTTTAAATATGGGCATTAATTTCATTTCAGTTCGTTCA
1841 CTCATTCCATTCATTTATCATTTCACAAACATTTGAAATCCTAATATAAGCAAGGTGCTCTGTTTAAGGCAGAAATTTGA
1921 AAATGTACAAGATATATGGTCTTGTCTTTAAGGAGCTGTTCATCTAGAATGGAGGAATTTACACTGATAATTATTCCTAC
2001 ACTTGAAACAAAGAAATTAACTCTCAAATTGCGTGGCAAGCATATATAGACTTTGCTATAAATATTTATGAAATGAGTTA
2081 CTGTTTTCCTTAAAAAAGCTAAGACTAAGGGCTGGCAATCAAATAAGAGCAAATTTAGTGGTGAACGTAGAACTGCCCAC
2161 TACCAGCTAGAGTCTCCAACCTAAAAGTCCCATGTTGCTAGTGATCCCCAGGGGTTTTATAGAAGGAATCCCTGCATTGG
2241 CAGTAATTTTGGATTAGATGATCCCTAAGAGCACCATCAAGTCTTAGGATTCTATGAATTAGGAAATAAACCAAATTATA
2321 TATTTTCTAATACTGATCAGCTCATATTTTATCATCATGTCATGTCTGGCTTTCATACTTAGTCATAATTTACTTTCTGG
2401 GTCATTTAGAGGCTAGCGTTCTCTAAGGTCACTTCTGCTTGCACATTGTAGGATATTATTTAGTATGGCTTTAAGAATTC
2481 AATCTTTCCCCCTCTCCTTTATGGAATGTGTGTTTCCTCTATTTGTACACTTAACCTTTTGTCCTAAGTTTTTATTTTTA
2561 TGGATACTAATGAGTAACTTTGAGGTTGACACTAGACCCAAACAGATGCAAACAGCCACTTTCTGTCCTCTTGTGACACA
2641 GTTGAAACACTTTATCTCTTGTCTGCTGTTTGGAGTGTCCTGAAAGAAACACTGAAGTGGCAGTCAACAGAGCAAGGGTA
2721 ACAGGATCTTTAAATAATTTAAAGTTGTCTGATCTTGACATAAAAGTGAACCCTTTCTTTAAAATTTCTAGCAACTGCTC
2801 TTAAGTCATAGGTTCCTCATTTTTTCTTTGCTGGTAGTGGGAGAAAATAGTTGATCTGTGATTTTTGTTTTCATCTCCCC
2881 AAACTATGTTATAAAGGCAGTAATTTGATGCTGAAGATTATGATTAGAAATCCTCAGATGGGTTATATATTGGGGCTTTA
2961 TCTTTTAATATTAAAAAGAATGTCTTTCCTGGACTACTTTATTCAGTAGTAAGCACTATTCATTCTATGTATATTCCTTA
3041 TTCAGCCTTGCAGACTCCTGTGGGATCTGATCTCTTCCTGCTTCAACTCAGTACCATACTCACCAAGGCTTAGTATGTCT
3121 TCACCCACTCTCCCTTCTCTTGCATTCCTCAAACATGCTGAGTTTATTCCAGCCTTAAGCCTTTGATCTACGCATCAGAA
3201 ATGTTGGGCCCCACTTCAGATCTTCTCTGCCCTGCCTTCTACTCCAGTCACTGCTGTGGTAACTAATTCCATGAAGTCTT
3281 TGACCAGGTTCTCAGAGAATATGATAGTACCTCTCTTTGGATTCTAGCTGTATACCTTTCACTTCAGCCTCCCTGACGTG
3361 GAATGTCTGCAGAACTTGTTTGGTACTCCCAATTGCACAGCCCAAAGGTGCAGGGGAGTTAGGTGCCCATGGGGCCATCC
3441 TTGACCTAGGTGGAAAGTTGCTAGTGGATAACTGATTACTCTTTTCATCACCTGGGCAGACAGTTCTGAAATGCATTTCG
3521 TAAGTCTCCTCAAAAGAGGAGGAGACTTCTGTGGCGGGTTTGGCAATAACCATCCTTATATTGGCTTTCCTCTTTTGTTT
3601 CACTCCTGTGCATCTCTCTTGCATCCTGGGATCGCTTCTCAAATAAATGACTTTCATTCAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agucggcgACAGUGUGCGUGUc 5'
                  ||| |:||||||| 
Target 5' tggtaaaaTGTGATACGCACAa 3'
494 - 515 158.00 -16.60
2
miRNA  3' agUCGGCGACAGUGUGCGU-GUc 5'
            |||| :|| : :||||| || 
Target 5' taAGCCTTTGATCTACGCATCAg 3'
3176 - 3198 132.00 -19.20
3
miRNA  3' agucggCGACAGUG--UGCGUGUc 5'
                |:||  ||  |:|:||| 
Target 5' gggataGTTGGAACTAATGTACAg 3'
1250 - 1273 118.00 -14.52
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31557844 20 COSMIC
COSN30508881 31 COSMIC
COSN29276807 32 COSMIC
COSN31561392 43 COSMIC
COSN31501551 45 COSMIC
COSN30473020 49 COSMIC
COSN30481187 55 COSMIC
COSN30536354 84 COSMIC
COSN30150373 97 COSMIC
COSN30488036 99 COSMIC
COSN30519887 127 COSMIC
COSN30165382 231 COSMIC
COSN1316328 400 COSMIC
COSN513046 418 COSMIC
COSN31556646 933 COSMIC
COSN31555014 979 COSMIC
COSN20101196 1023 COSMIC
COSN31489175 1223 COSMIC
COSN26679675 1443 COSMIC
COSN17372536 1524 COSMIC
COSN28769098 1525 COSMIC
COSN2106993 1628 COSMIC
COSN31520426 1654 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs749894583 1 dbSNP
rs767139292 5 dbSNP
rs1298461533 7 dbSNP
rs756856972 11 dbSNP
rs1352206188 12 dbSNP
rs560448931 13 dbSNP
rs375488662 14 dbSNP
rs941843706 16 dbSNP
rs1435216966 25 dbSNP
rs1331976464 26 dbSNP
rs765819768 29 dbSNP
rs1191495655 30 dbSNP
rs1047585268 33 dbSNP
rs754558868 34 dbSNP
rs1177938851 35 dbSNP
rs1480432689 38 dbSNP
rs1231204204 39 dbSNP
rs777006891 40 dbSNP
rs1349200467 41 dbSNP
rs1280285209 43 dbSNP
rs938449211 44 dbSNP
rs766543937 45 dbSNP
rs1323838389 46 dbSNP
rs1319168631 47 dbSNP
rs1308181628 50 dbSNP
rs1390396715 51 dbSNP
rs1224567817 52 dbSNP
rs540202987 55 dbSNP
rs994131777 62 dbSNP
rs185527688 72 dbSNP
rs1182349849 77 dbSNP
rs554841570 79 dbSNP
rs1239832252 84 dbSNP
rs1474025581 86 dbSNP
rs1318870164 104 dbSNP
rs146535915 109 dbSNP
rs1407476653 110 dbSNP
rs916834650 110 dbSNP
rs1354524188 111 dbSNP
rs1410967824 121 dbSNP
rs1290296015 123 dbSNP
rs989653364 137 dbSNP
rs1232924325 138 dbSNP
rs958208852 143 dbSNP
rs373050468 149 dbSNP
rs759278474 151 dbSNP
rs1012314120 152 dbSNP
rs1270612281 153 dbSNP
rs894912334 154 dbSNP
rs143673457 156 dbSNP
rs1398587252 166 dbSNP
rs193190656 167 dbSNP
rs1484379862 174 dbSNP
rs904667480 175 dbSNP
rs1368731439 176 dbSNP
rs751239724 179 dbSNP
rs377247953 181 dbSNP
rs1365033501 189 dbSNP
rs946341483 200 dbSNP
rs1173736775 213 dbSNP
rs1038029080 220 dbSNP
rs558703758 227 dbSNP
rs1334895869 231 dbSNP
rs1342550221 234 dbSNP
rs538687876 252 dbSNP
rs1225515715 253 dbSNP
rs1268209295 268 dbSNP
rs1429683023 271 dbSNP
rs1229083930 282 dbSNP
rs1276735353 283 dbSNP
rs1006175019 289 dbSNP
rs148897882 291 dbSNP
rs113361868 292 dbSNP
rs1047618845 304 dbSNP
rs1256231066 306 dbSNP
rs938481711 313 dbSNP
rs942651146 314 dbSNP
rs1445114613 325 dbSNP
rs911312074 326 dbSNP
rs1190502711 330 dbSNP
rs1260941809 335 dbSNP
rs1205652504 339 dbSNP
rs3190618 342 dbSNP
rs984169987 348 dbSNP
rs1450436962 351 dbSNP
rs952764659 352 dbSNP
rs1261366184 354 dbSNP
rs918465230 364 dbSNP
rs560924921 365 dbSNP
rs1285489183 374 dbSNP
rs770343925 379 dbSNP
rs972961413 387 dbSNP
rs970699393 396 dbSNP
rs1380760713 397 dbSNP
rs117080617 399 dbSNP
rs1326280577 400 dbSNP
rs1296833948 409 dbSNP
rs1011933748 414 dbSNP
rs1368777712 415 dbSNP
rs1232358620 419 dbSNP
rs958321555 420 dbSNP
rs1346443477 424 dbSNP
rs1203037518 429 dbSNP
rs1362482426 434 dbSNP
rs1267147727 435 dbSNP
rs865808289 441 dbSNP
rs1190971361 451 dbSNP
rs1251518493 453 dbSNP
rs534266189 458 dbSNP
rs746571490 459 dbSNP
rs1200132509 462 dbSNP
rs1032062359 465 dbSNP
rs1379470705 465 dbSNP
rs35139986 469 dbSNP
rs1468870428 471 dbSNP
rs1406327900 476 dbSNP
rs1158487117 481 dbSNP
rs1389733093 484 dbSNP
rs1000606372 492 dbSNP
rs78269314 493 dbSNP
rs548445407 496 dbSNP
rs1474300056 505 dbSNP
rs1301843777 506 dbSNP
rs1372304684 506 dbSNP
rs1386162381 506 dbSNP
rs779265082 509 dbSNP
rs531801748 510 dbSNP
rs1430269809 513 dbSNP
rs1030851772 523 dbSNP
rs1329512047 530 dbSNP
rs13659 533 dbSNP
rs1461878298 552 dbSNP
rs1265231027 554 dbSNP
rs1194298607 558 dbSNP
rs965147455 558 dbSNP
rs1339074872 562 dbSNP
rs1016304119 566 dbSNP
rs1270153293 569 dbSNP
rs1006204823 575 dbSNP
rs1381186678 587 dbSNP
rs1412708749 590 dbSNP
rs1473702440 591 dbSNP
rs1315026124 593 dbSNP
rs1347932821 595 dbSNP
rs886385529 596 dbSNP
rs1293876989 597 dbSNP
rs149717173 609 dbSNP
rs1407918013 612 dbSNP
rs1306877356 620 dbSNP
rs1002724943 623 dbSNP
rs1229881692 624 dbSNP
rs1338232381 629 dbSNP
rs906995801 644 dbSNP
rs1312913918 648 dbSNP
rs1320714075 650 dbSNP
rs1246057362 652 dbSNP
rs1407884463 661 dbSNP
rs766889557 663 dbSNP
rs1252653789 665 dbSNP
rs140466160 672 dbSNP
rs948532167 678 dbSNP
rs892875304 687 dbSNP
rs1463380983 699 dbSNP
rs1054073921 705 dbSNP
rs1182985630 706 dbSNP
rs1445245970 707 dbSNP
rs1427758780 713 dbSNP
rs934317878 718 dbSNP
rs1245054917 720 dbSNP
rs1179856662 726 dbSNP
rs1437493213 735 dbSNP
rs111507013 740 dbSNP
rs1197901959 741 dbSNP
rs556558650 743 dbSNP
rs1396178148 744 dbSNP
rs1357814061 752 dbSNP
rs1050325 753 dbSNP
rs1247350655 761 dbSNP
rs1244953854 763 dbSNP
rs1276022194 766 dbSNP
rs1344906422 771 dbSNP
rs530047928 772 dbSNP
rs933488702 780 dbSNP
rs1236973933 782 dbSNP
rs1483704972 796 dbSNP
rs923497009 798 dbSNP
rs1258041579 801 dbSNP
rs1359477379 807 dbSNP
rs975312379 813 dbSNP
rs73096660 816 dbSNP
rs1431541884 817 dbSNP
rs868662199 825 dbSNP
rs1016344462 834 dbSNP
rs1466248417 844 dbSNP
rs756526047 860 dbSNP
rs1362538544 866 dbSNP
rs950670816 868 dbSNP
rs1298779335 878 dbSNP
rs1329200496 886 dbSNP
rs544487089 891 dbSNP
rs1278022521 892 dbSNP
rs1312802037 897 dbSNP
rs575520375 903 dbSNP
rs1002759844 908 dbSNP
rs907108352 910 dbSNP
rs1187767791 917 dbSNP
rs1248334928 919 dbSNP
rs1451265761 919 dbSNP
rs1189345868 920 dbSNP
rs1363494960 928 dbSNP
rs1022836762 940 dbSNP
rs1013146304 947 dbSNP
rs1386072912 950 dbSNP
rs1162785109 953 dbSNP
rs866945240 964 dbSNP
rs1174641120 977 dbSNP
rs892917174 992 dbSNP
rs781469161 1005 dbSNP
rs1054106124 1006 dbSNP
rs1387119639 1015 dbSNP
rs1156857631 1016 dbSNP
rs1434976865 1018 dbSNP
rs200321681 1021 dbSNP
rs1233652915 1022 dbSNP
rs1274739625 1023 dbSNP
rs934347175 1026 dbSNP
rs1328757443 1039 dbSNP
rs1383516546 1039 dbSNP
rs879117446 1039 dbSNP
rs902819610 1040 dbSNP
rs973420223 1042 dbSNP
rs963427426 1044 dbSNP
rs1223829054 1046 dbSNP
rs1490975221 1049 dbSNP
rs1282828423 1053 dbSNP
rs1014996241 1058 dbSNP
rs761215917 1070 dbSNP
rs1478307672 1079 dbSNP
rs1192492679 1085 dbSNP
rs1050708076 1097 dbSNP
rs60592133 1103 dbSNP
rs544824343 1109 dbSNP
rs182610650 1118 dbSNP
rs943504049 1121 dbSNP
rs1343354775 1122 dbSNP
rs1351036953 1127 dbSNP
rs1302340044 1130 dbSNP
rs1405371161 1131 dbSNP
rs1351521426 1140 dbSNP
rs1316205066 1142 dbSNP
rs909314261 1149 dbSNP
rs1306270416 1154 dbSNP
rs984833065 1157 dbSNP
rs1408810317 1161 dbSNP
rs1229273931 1166 dbSNP
rs1290485517 1169 dbSNP
rs375350417 1172 dbSNP
rs1226454722 1173 dbSNP
rs1288873692 1180 dbSNP
rs1026353559 1186 dbSNP
rs1224554636 1194 dbSNP
rs981848246 1202 dbSNP
rs1200574220 1206 dbSNP
rs1481659355 1207 dbSNP
rs1240866161 1208 dbSNP
rs1215714005 1210 dbSNP
rs1471600971 1212 dbSNP
rs1163112767 1213 dbSNP
rs1445863849 1213 dbSNP
rs1284367567 1214 dbSNP
rs1210159232 1215 dbSNP
rs971362757 1216 dbSNP
rs1320928224 1220 dbSNP
rs1282292280 1225 dbSNP
rs1223882649 1228 dbSNP
rs1369546315 1230 dbSNP
rs1268276920 1231 dbSNP
rs1429953103 1232 dbSNP
rs1167213654 1234 dbSNP
rs1345823085 1234 dbSNP
rs1322606588 1236 dbSNP
rs1370448833 1236 dbSNP
rs1468344145 1244 dbSNP
rs1309916647 1253 dbSNP
rs1338994499 1254 dbSNP
rs1447487836 1254 dbSNP
rs1283398115 1256 dbSNP
rs1356728130 1258 dbSNP
rs1248121922 1264 dbSNP
rs1272444669 1268 dbSNP
rs1341347527 1272 dbSNP
rs1023291161 1285 dbSNP
rs1012766823 1311 dbSNP
rs1186335226 1316 dbSNP
rs1238442278 1321 dbSNP
rs1177512985 1325 dbSNP
rs1446861490 1326 dbSNP
rs1187041079 1332 dbSNP
rs1435212020 1335 dbSNP
rs1390164094 1339 dbSNP
rs1417833775 1341 dbSNP
rs1186398305 1342 dbSNP
rs781514172 1345 dbSNP
rs769292731 1347 dbSNP
rs1400086659 1360 dbSNP
rs559941634 1360 dbSNP
rs1414143384 1364 dbSNP
rs957181338 1366 dbSNP
rs1476043427 1377 dbSNP
rs1244371679 1378 dbSNP
rs552721222 1385 dbSNP
rs1454423384 1389 dbSNP
rs1189908802 1393 dbSNP
rs1364458262 1409 dbSNP
rs1050336 1414 dbSNP
rs1252573359 1418 dbSNP
rs998529320 1424 dbSNP
rs1199356614 1429 dbSNP
rs1262114632 1431 dbSNP
rs1278950843 1431 dbSNP
rs1207299628 1442 dbSNP
rs902936015 1451 dbSNP
rs1247724158 1455 dbSNP
rs1450653658 1468 dbSNP
rs1195893499 1473 dbSNP
rs1203908339 1474 dbSNP
rs1477764045 1492 dbSNP
rs1173215829 1497 dbSNP
rs1408653523 1504 dbSNP
rs1455842819 1523 dbSNP
rs1313673973 1524 dbSNP
rs6814 1525 dbSNP
rs998244349 1527 dbSNP
rs112799627 1533 dbSNP
rs1329251517 1542 dbSNP
rs1231960792 1552 dbSNP
rs1299809127 1555 dbSNP
rs1039670734 1564 dbSNP
rs943551280 1566 dbSNP
rs909345339 1567 dbSNP
rs1337574621 1568 dbSNP
rs1049251604 1579 dbSNP
rs1451526411 1582 dbSNP
rs1467796959 1583 dbSNP
rs1353076602 1588 dbSNP
rs1431460164 1594 dbSNP
rs1170148287 1599 dbSNP
rs1471743557 1602 dbSNP
rs929415928 1605 dbSNP
rs1412930262 1606 dbSNP
rs186688579 1620 dbSNP
rs112897311 1634 dbSNP
rs569153294 1635 dbSNP
rs1386078565 1636 dbSNP
rs552725957 1639 dbSNP
rs1346794409 1640 dbSNP
rs1162294014 1641 dbSNP
rs879438359 1649 dbSNP
rs1226222812 1655 dbSNP
rs1287374760 1659 dbSNP
rs1329397032 1661 dbSNP
rs751678988 1662 dbSNP
rs981494630 1663 dbSNP
rs1356270835 1687 dbSNP
rs1442167892 1691 dbSNP
rs1242000270 1692 dbSNP
rs763901296 1698 dbSNP
rs1482135240 1704 dbSNP
rs1336448842 1713 dbSNP
rs971777108 1717 dbSNP
rs1252880769 1718 dbSNP
rs1421101455 1724 dbSNP
rs1161024264 1730 dbSNP
rs115155684 1731 dbSNP
rs1457365700 1741 dbSNP
rs1230871239 1744 dbSNP
rs566937312 1745 dbSNP
rs991778019 1764 dbSNP
rs1407510536 1768 dbSNP
rs1293581253 1769 dbSNP
rs1306861020 1770 dbSNP
rs957211062 1773 dbSNP
rs762993045 1777 dbSNP
rs901441762 1779 dbSNP
rs1041653932 1790 dbSNP
rs755079991 1790 dbSNP
rs1307927552 1794 dbSNP
rs1245941430 1797 dbSNP
rs1294643605 1801 dbSNP
rs967126452 1805 dbSNP
rs942685252 1812 dbSNP
rs1275355436 1815 dbSNP
rs1481749057 1832 dbSNP
rs1180286728 1835 dbSNP
rs911259640 1836 dbSNP
rs546753049 1839 dbSNP
rs997880130 1842 dbSNP
rs1048422506 1849 dbSNP
rs1358760141 1853 dbSNP
rs139575625 1857 dbSNP
rs1039294534 1865 dbSNP
rs1397898437 1870 dbSNP
rs918654827 1873 dbSNP
rs1167423013 1880 dbSNP
rs1354559878 1884 dbSNP
rs1007847388 1893 dbSNP
rs561228194 1895 dbSNP
rs970943726 1897 dbSNP
rs917846416 1899 dbSNP
rs990664912 1901 dbSNP
rs1453907827 1916 dbSNP
rs369021829 1916 dbSNP
rs1317603990 1926 dbSNP
rs6863234 1927 dbSNP
rs929446903 1929 dbSNP
rs1296410623 1933 dbSNP
rs1309301535 1934 dbSNP
rs919354489 1942 dbSNP
rs1208059689 1955 dbSNP
rs1255650750 1956 dbSNP
rs1297875119 1958 dbSNP
rs1204061925 1964 dbSNP
rs1032008622 1969 dbSNP
rs1046210659 1970 dbSNP
rs1447641621 1971 dbSNP
rs34965256 1996 dbSNP
rs115723440 2009 dbSNP
rs991500383 2018 dbSNP
rs1173275276 2023 dbSNP
rs759472705 2032 dbSNP
rs545172775 2033 dbSNP
rs1384032754 2040 dbSNP
rs572922851 2042 dbSNP
rs182353223 2055 dbSNP
rs967158928 2058 dbSNP
rs542273195 2059 dbSNP
rs1029416252 2062 dbSNP
rs1176271330 2068 dbSNP
rs1225563942 2071 dbSNP
rs766105007 2078 dbSNP
rs1264823203 2098 dbSNP
rs1463349745 2103 dbSNP
rs1007186804 2115 dbSNP
rs1242650532 2116 dbSNP
rs1253738631 2118 dbSNP
rs1189021295 2128 dbSNP
rs1220112329 2133 dbSNP
rs1480588335 2138 dbSNP
rs760056251 2145 dbSNP
rs113554175 2146 dbSNP
rs1018397376 2147 dbSNP
rs1247062525 2152 dbSNP
rs1319325301 2154 dbSNP
rs1005205373 2162 dbSNP
rs772782395 2164 dbSNP
rs556534091 2172 dbSNP
rs749068283 2187 dbSNP
rs1027879757 2189 dbSNP
rs538185834 2200 dbSNP
rs1407034736 2208 dbSNP
rs918697992 2209 dbSNP
rs1037484364 2210 dbSNP
rs949258674 2211 dbSNP
rs1223006411 2219 dbSNP
rs749779783 2219 dbSNP
rs1045824583 2237 dbSNP
rs776042129 2264 dbSNP
rs950215337 2267 dbSNP
rs917779916 2271 dbSNP
rs1267608098 2296 dbSNP
rs1490379810 2314 dbSNP
rs1200899866 2318 dbSNP
rs990612432 2321 dbSNP
rs1472021818 2322 dbSNP
rs575876017 2323 dbSNP
rs937955270 2329 dbSNP
rs770110269 2342 dbSNP
rs925172203 2351 dbSNP
rs1410600006 2357 dbSNP
rs979083831 2358 dbSNP
rs536771186 2359 dbSNP
rs935973031 2360 dbSNP
rs1366687442 2364 dbSNP
rs1406863761 2365 dbSNP
rs966737384 2367 dbSNP
rs569346903 2386 dbSNP
rs977269208 2393 dbSNP
rs1472733586 2399 dbSNP
rs1413775403 2410 dbSNP
rs1226361059 2412 dbSNP
rs976270402 2416 dbSNP
rs539932398 2417 dbSNP
rs1464438988 2418 dbSNP
rs922460390 2431 dbSNP
rs1480018438 2437 dbSNP
rs1436921113 2444 dbSNP
rs539246369 2445 dbSNP
rs148082086 2461 dbSNP
rs371805280 2461 dbSNP
rs190743578 2464 dbSNP
rs1386420223 2473 dbSNP
rs547082764 2482 dbSNP
rs1209551423 2484 dbSNP
rs116437520 2485 dbSNP
rs1370005973 2486 dbSNP
rs1331167454 2488 dbSNP
rs1357595320 2488 dbSNP
rs983801983 2488 dbSNP
rs952334464 2490 dbSNP
rs574196636 2500 dbSNP
rs995523477 2505 dbSNP
rs897116458 2508 dbSNP
rs1037028705 2510 dbSNP
rs757526504 2525 dbSNP
rs745842301 2530 dbSNP
rs567711564 2533 dbSNP
rs370160005 2534 dbSNP
rs1195827398 2537 dbSNP
rs949541369 2544 dbSNP
rs1274700701 2546 dbSNP
rs1440279325 2552 dbSNP
rs1203507931 2560 dbSNP
rs1244120978 2563 dbSNP
rs1447033535 2572 dbSNP
rs1187193931 2579 dbSNP
rs780847279 2588 dbSNP
rs1055781912 2590 dbSNP
rs1287754125 2591 dbSNP
rs1054895819 2597 dbSNP
rs1457353175 2598 dbSNP
rs937820977 2599 dbSNP
rs1169667917 2600 dbSNP
rs936004276 2602 dbSNP
rs925202755 2609 dbSNP
rs201778244 2612 dbSNP
rs945304759 2617 dbSNP
rs913597505 2619 dbSNP
rs1454549711 2623 dbSNP
rs1318493107 2629 dbSNP
rs1325732068 2633 dbSNP
rs1469036871 2637 dbSNP
rs1378002136 2641 dbSNP
rs1200849099 2642 dbSNP
rs1426693749 2648 dbSNP
rs1342517111 2654 dbSNP
rs975754726 2658 dbSNP
rs1261003590 2661 dbSNP
rs1222502410 2662 dbSNP
rs1264189611 2671 dbSNP
rs966215097 2674 dbSNP
rs1017338138 2680 dbSNP
rs1462962337 2683 dbSNP
rs1189282757 2688 dbSNP
rs778016540 2696 dbSNP
rs1207164273 2705 dbSNP
rs985645528 2707 dbSNP
rs758610449 2717 dbSNP
rs1041692486 2718 dbSNP
rs752680874 2726 dbSNP
rs1480259673 2737 dbSNP
rs996197907 2747 dbSNP
rs1203288663 2756 dbSNP
rs897404962 2757 dbSNP
rs1431663898 2767 dbSNP
rs1346094976 2786 dbSNP
rs1470845331 2791 dbSNP
rs1156527727 2794 dbSNP
rs942521005 2795 dbSNP
rs1319778500 2802 dbSNP
rs1254101905 2811 dbSNP
rs1258171355 2819 dbSNP
rs1328820331 2837 dbSNP
rs1403754853 2856 dbSNP
rs1016036199 2865 dbSNP
rs1545753 2867 dbSNP
rs1260500868 2880 dbSNP
rs896592253 2886 dbSNP
rs1207385296 2888 dbSNP
rs1265405774 2892 dbSNP
rs1055092386 2897 dbSNP
rs972391179 2900 dbSNP
rs937852157 2905 dbSNP
rs565206314 2910 dbSNP
rs1043538847 2915 dbSNP
rs543878501 2916 dbSNP
rs1034404255 2930 dbSNP
rs1451487052 2935 dbSNP
rs913805728 2946 dbSNP
rs112144941 2949 dbSNP
rs904613586 2956 dbSNP
rs1423471839 2962 dbSNP
rs765551274 2966 dbSNP
rs944365576 2968 dbSNP
rs1478436 2978 dbSNP
rs1306797984 2989 dbSNP
rs539375103 2996 dbSNP
rs1336693364 3012 dbSNP
rs1241571004 3015 dbSNP
rs1264223438 3018 dbSNP
rs1359274790 3028 dbSNP
rs901098643 3029 dbSNP
rs2290995 3034 dbSNP
rs1294032073 3035 dbSNP
rs951770693 3040 dbSNP
rs1482227030 3044 dbSNP
rs1176808524 3053 dbSNP
rs573390579 3054 dbSNP
rs920133462 3056 dbSNP
rs1419480082 3057 dbSNP
rs974251540 3078 dbSNP
rs1183186838 3086 dbSNP
rs1443187094 3091 dbSNP
rs753689858 3095 dbSNP
rs1366870146 3103 dbSNP
rs1460185856 3124 dbSNP
rs116110622 3127 dbSNP
rs1194420075 3131 dbSNP
rs1014005210 3133 dbSNP
rs1396706074 3133 dbSNP
rs1048251274 3155 dbSNP
rs1339208271 3157 dbSNP
rs376940373 3166 dbSNP
rs1275889990 3173 dbSNP
rs1247325340 3174 dbSNP
rs760388384 3179 dbSNP
rs1231269983 3186 dbSNP
rs960658459 3187 dbSNP
rs187610741 3191 dbSNP
rs577540046 3192 dbSNP
rs1252125208 3193 dbSNP
rs1481703414 3194 dbSNP
rs559221478 3195 dbSNP
rs1197406013 3203 dbSNP
rs1196501632 3205 dbSNP
rs972821531 3209 dbSNP
rs148583326 3211 dbSNP
rs1184097045 3213 dbSNP
rs573389676 3219 dbSNP
rs1340677896 3221 dbSNP
rs1373292318 3227 dbSNP
rs1463191887 3227 dbSNP
rs1335208529 3231 dbSNP
rs1405775254 3239 dbSNP
rs1335854828 3242 dbSNP
rs1453790774 3250 dbSNP
rs1339298872 3269 dbSNP
rs970393821 3275 dbSNP
rs182002544 3276 dbSNP
rs767008062 3282 dbSNP
rs1395525585 3283 dbSNP
rs761352501 3285 dbSNP
rs1261064935 3298 dbSNP
rs917491562 3304 dbSNP
rs1043980716 3306 dbSNP
rs959204093 3311 dbSNP
rs1034517444 3319 dbSNP
rs1000301603 3326 dbSNP
rs1261795339 3330 dbSNP
rs1429975595 3334 dbSNP
rs1173855613 3335 dbSNP
rs536785066 3336 dbSNP
rs1470517083 3345 dbSNP
rs1178948109 3351 dbSNP
rs113565649 3357 dbSNP
rs1469694951 3358 dbSNP
rs892397376 3359 dbSNP
rs551023515 3364 dbSNP
rs537467900 3383 dbSNP
rs1282907453 3397 dbSNP
rs1324465262 3402 dbSNP
rs149431512 3408 dbSNP
rs7712325 3411 dbSNP
rs770304687 3425 dbSNP
rs910254446 3427 dbSNP
rs1207868849 3429 dbSNP
rs1050087865 3435 dbSNP
rs1041368999 3449 dbSNP
rs528371035 3452 dbSNP
rs1486576263 3453 dbSNP
rs889707544 3454 dbSNP
rs1267742834 3461 dbSNP
rs1048283364 3468 dbSNP
rs1202121346 3480 dbSNP
rs931102839 3484 dbSNP
rs1400677406 3489 dbSNP
rs746174600 3496 dbSNP
rs536698806 3498 dbSNP
rs920330947 3514 dbSNP
rs974662094 3519 dbSNP
rs961527404 3520 dbSNP
rs908793267 3521 dbSNP
rs777061569 3526 dbSNP
rs1370954223 3533 dbSNP
rs191961186 3538 dbSNP
rs1222948160 3545 dbSNP
rs1284891481 3548 dbSNP
rs1319562917 3549 dbSNP
rs992455161 3551 dbSNP
rs559536895 3555 dbSNP
rs62368920 3556 dbSNP
rs1290382295 3558 dbSNP
rs1039372434 3559 dbSNP
rs1033664796 3560 dbSNP
rs1405954588 3563 dbSNP
rs1223273628 3564 dbSNP
rs999898880 3570 dbSNP
rs1392982366 3575 dbSNP
rs528980233 3577 dbSNP
rs917623922 3578 dbSNP
rs904262364 3583 dbSNP
rs1002146523 3584 dbSNP
rs968116849 3585 dbSNP
rs1410805764 3587 dbSNP
rs1443318669 3597 dbSNP
rs77438610 3599 dbSNP
rs1413024792 3602 dbSNP
rs937618147 3604 dbSNP
rs1327133263 3605 dbSNP
rs1009819631 3610 dbSNP
rs543081156 3611 dbSNP
rs1279922622 3612 dbSNP
rs1379101077 3624 dbSNP
rs1243654931 3626 dbSNP
rs368349959 3629 dbSNP
rs1040602972 3633 dbSNP
rs927536415 3634 dbSNP
rs1479694040 3640 dbSNP
rs1268719437 3655 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions Jiyoye
Tools used in this research TargetScan
Original Description (Extracted from the article) ... HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO2. ...

- Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al., 2012, The EMBO journal.

Article - Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al.
- The EMBO journal, 2012
Epstein-Barr virus (EBV) controls gene expression to transform human B cells and maintain viral latency. High-throughput sequencing and crosslinking immunoprecipitation (HITS-CLIP) identified mRNA targets of 44 EBV and 310 human microRNAs (miRNAs) in Jijoye (Latency III) EBV-transformed B cells. While 25% of total cellular miRNAs are viral, only three viral mRNAs, all latent transcripts, are targeted. Thus, miRNAs do not control the latent/lytic switch by targeting EBV lytic genes. Unexpectedly, 90% of the 1664 human 3'-untranslated regions targeted by the 12 most abundant EBV miRNAs are also targeted by human miRNAs via distinct binding sites. Half of these are targets of the oncogenic miR-17 approximately 92 miRNA cluster and associated families, including mRNAs that regulate transcription, apoptosis, Wnt signalling, and the cell cycle. Reporter assays confirmed the functionality of several EBV and miR-17 family miRNA-binding sites in EBV latent membrane protein 1 (LMP1), EBV BHRF1, and host CAPRIN2 mRNAs. Our extensive list of EBV and human miRNA targets implicates miRNAs in the control of EBV latency and illuminates viral miRNA function in general.
LinkOut: [PMID: 22473208]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions C8166
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3 ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agucggcgacAGUGUGCGUGUc 5'
                    | |:||||||| 
Target 5' ----------UGAUACGCACAa 3'
1 - 12
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462572
Method / RBP PAR-CLIP / AGO2
Cell line / Condition C8166 / C8166 NL4-3
Location of target site ENST00000325110.6 | 3UTR | UGAUACGCACAAACCCUUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
STAD 0.483 0 0.508 0 32 Click to see details
BLCA 0.596 0 0.585 0.01 18 Click to see details
PAAD -0.974 0.01 -1.000 0.5 4 Click to see details
KICH 0.319 0.06 0.377 0.03 25 Click to see details
ESCA 0.418 0.1 0.182 0.3 11 Click to see details
HNSC 0.171 0.14 0.070 0.33 42 Click to see details
LIHC 0.151 0.15 0.121 0.2 49 Click to see details
COAD -0.375 0.18 -0.262 0.27 8 Click to see details
THCA -0.108 0.21 -0.067 0.31 59 Click to see details
PCPG 0.784 0.21 0.500 0.33 3 Click to see details
CHOL 0.284 0.23 0.433 0.12 9 Click to see details
PRAD -0.099 0.25 -0.072 0.31 50 Click to see details
KIRP 0.124 0.25 0.084 0.32 32 Click to see details
UCEC 0.149 0.27 0.221 0.18 19 Click to see details
LUAD 0.176 0.29 0.084 0.4 12 Click to see details
LUSC 0.075 0.33 0.087 0.3 38 Click to see details
BRCA 0.044 0.35 0.051 0.32 84 Click to see details
KIRC 0.04 0.37 0.000 0.5 68 Click to see details
CESC 0.291 0.41 -0.500 0.33 3 Click to see details
CESC 0.291 0.41 -0.500 0.33 3 Click to see details
CESC 0.291 0.41 -0.500 0.33 3 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission